Literature DB >> 3081519

Structural characterization of a chain termination mutant of human serum albumin.

M Galliano, L Minchiotti, P Iadarola, M C Zapponi, G Ferri, A A Castellani.   

Abstract

Mutant forms of human serum albumin have been detected on the basis of their abnormal electrophoretic mobility which is either faster or slower than that of normal albumin. In the present work we have studied the structure of a slow variant, referred to as albumin Ge/Ct, in order to define the cause of its genetic abnormality. The protein was isolated from the serum of a young healthy woman homozygous for the variant. Analysis of CNBr fragments by isoelectric focusing allowed us to localize the mutation to the COOH-terminal region of the molecule (residues 549-585). This fragment was isolated on a preparative scale and subjected to tryptic digestion. All tryptic peptides were purified by reverse-phase high performance liquid chromatography and characterized. Sequential analysis of three abnormal peptides revealed that albumin Ge/Ct has a shortened chain with the following COOH-terminal sequence: Leu-Val-Ala-Ala-Ser-Lys580-Leu-Pro. The presence of an additional lysine residue accounts for the electrophoretic behavior of the variant. It is likely that the variant may be caused by a single base deletion in the structural gene, a Cyt in mRNA codon 580, and the consequent shift in reading frame.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3081519

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Hemophilia B (factor IXSeattle 2) due to a single nucleotide deletion in the gene for factor IX.

Authors:  B G Schach; S Yoshitake; E W Davie
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

2.  Identical structural changes in inherited albumin variants from different populations.

Authors:  K Arai; N Ishioka; K Huss; J Madison; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

3.  Amino acid substitutions in genetic variants of human serum albumin and in sequences inferred from molecular cloning.

Authors:  N Takahashi; Y Takahashi; B S Blumberg; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

4.  Amino acid substitutions in inherited albumin variants from Amerindian and Japanese populations.

Authors:  N Takahashi; Y Takahashi; T Isobe; F W Putnam; M Fujita; C Satoh; J V Neel
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

5.  Point substitutions in albumin genetic variants from Asia.

Authors:  K Arai; J Madison; A Shimizu; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

6.  Mutations in genetic variants of human serum albumin found in Italy.

Authors:  M Galliano; L Minchiotti; F Porta; A Rossi; G Ferri; J Madison; S Watkins; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

7.  A donor splice mutation and a single-base deletion produce two carboxyl-terminal variants of human serum albumin.

Authors:  S Watkins; J Madison; E Davis; Y Sakamoto; M Galliano; L Minchiotti; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

8.  Structural changes and metal binding by proalbumins and other amino-terminal genetic variants of human serum albumin.

Authors:  N Takahashi; Y Takahashi; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

9.  Hypermutability of CpG dinucleotides in the propeptide-encoding sequence of the human albumin gene.

Authors:  S O Brennan; K Arai; J Madison; C B Laurell; M Galliano; S Watkins; R Peach; T Myles; P George; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

10.  120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A.

Authors:  P E Zimmerman; D R Voelker; F X McCormack; J R Paulsrud; W J Martin
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.